| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at Edgewise Therapeutics, Inc. with holdings across 36 companies. Recent SEC Form 4 filings include 17 buys and 3 sells.
Estimated insider holdings value: $2043.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2022 | TERN Terns Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 137,931 | $7.25 | $999,999.75 | +2.9% | +10.3% | -20.5% | |
| Nov 8, 2022 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 402,000 | $3.21 | $1,290,420.00 | +2.7% | -7.3% | -59.5% | |
| Sep 16, 2022 | EWTX Edgewise Therapeutics, Inc. | Director, 10% Owner | Buy | 484,496 | $10.32 | $4,999,998.72 | +3.6% | -18.9% | -33.0% | |
| Aug 16, 2022 | TERN Terns Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 3,690,000 | $2.42 | $8,929,800.00 | +97.3% | -7.2% | +14.3% | |
| Jun 24, 2022 | ARQT Arcutis Biotherapeutics, Inc. | 10% Owner | Sell | 341,971 | $21.31 | $7,287,402.01 | -8.0% | -10.4% | -57.4% | |
| Jun 24, 2022 | IMA Imagenebio, Inc. | Director | Buy | 252,225 | $4.47 | $1,128,020.79 | +3.3% | -35.6% | +28.5% | |
| May 26, 2022 | PMVP Pmv Pharmaceuticals, Inc. | 10% Owner | Sell | 26,253 | $15.93 | $418,210.29 | -23.0% | +11.3% | -59.2% | |
| May 18, 2022 | EWTX Edgewise Therapeutics, Inc. | Director, 10% Owner | Buy | 138,000 | $7.21 | $994,980.00 | +1.0% | +51.1% | +28.2% | |
| May 13, 2022 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 192,516 | $2.18 | $420,481.68 | +0.4% | +8.3% | +28.1% | |
| May 10, 2022 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 125,359 | $1.57 | $197,251.92 | +0.3% | +58.5% | +105.5% |